@guidedbyisabel's GHK-Cu 'glow up' peptide claims, fact-checked

What did @guidedbyisabel actually say?

Honestly, almost nothing. The transcript captured here is basically "Okay, so we're gonna do So, so a small one Perfect!" which tells us next to nothing about specific claims. The video title and hashtags do the heavy lifting: GHK-Cu is framed as a "glow up peptide" with the implication that it delivers visible cosmetic or healing benefits. The caption and hashtag choices, specifically "healingpeptides" and "copper," suggest the creator is positioning GHK-Cu as both a cosmetic and regenerative compound. That framing is worth examining on its own, even without a detailed spoken claim, because 18,900 people watched this and walked away with some impression of what GHK-Cu does.

The "small one" reference likely points to a subcutaneous injection or topical application, but we cannot confirm that from the transcript alone. We are essentially fact-checking the framing more than the content here.

Does the science back this up?

Partially, yes, but the picture is more complicated than a TikTok caption can convey. GHK-Cu (glycine-histidine-lysine copper) is a naturally occurring copper peptide with a real and growing body of research behind it, mostly in vitro and animal studies, with some limited human data.

Pickart and Margolina (2018, Cosmetics) reviewed decades of GHK-Cu research and found evidence for increased collagen synthesis, wound contraction, and antioxidant gene expression in cell and animal models. A separate review by Pickart (2008, Life Sciences) described GHK-Cu as a broad-spectrum tissue remodeler that activates over 4,000 human genes. That sounds dramatic, and researchers have been cautious about overstating it, because gene expression changes in a petri dish do not automatically translate to clinical outcomes in humans.

Human clinical data is thin. Small trials in dermatology have shown some improvement in skin laxity and fine lines with topical GHK-Cu formulations, but sample sizes are small and funding sources are often tied to cosmetic companies. Injectable GHK-Cu is a different story with even less clinical evidence in humans.

What did they get wrong (or right)?

The "glow up peptide" framing is not technically wrong, but it is reductive in a way that matters. GHK-Cu has the most evidence for skin-related applications, so the cosmetic angle is at least consistent with the literature. Credit where it is due.

What is missing is any acknowledgment that most of the compelling GHK-Cu data comes from cell cultures and rodent models. Loren Pickart, who has published extensively on GHK-Cu, has himself noted that human trials are limited. Calling it a "glow up peptide" without that context turns a preliminary research compound into a proven cosmetic intervention, which it is not.

The hashtag "healingpeptides" is also doing a lot of unearned work. Healing is a broad, clinical-sounding claim. GHK-Cu shows wound-healing properties in preclinical models, but presenting it casually as a healing compound to a general audience without clinical qualification is the kind of framing that regulatory bodies like the FTC and FDA pay attention to.

What should you actually know?

GHK-Cu is a legitimate research compound with a plausible mechanism and real scientific interest. It is not a proven therapeutic by current clinical standards. The difference matters, especially on a platform where viewers may be making purchasing or injection decisions based on a 15-second clip.

Topical GHK-Cu has more supporting evidence than injectable formulations for cosmetic outcomes. If someone is considering injectable GHK-Cu, that decision should happen inside a supervised telehealth or clinical context, not based on social media framing. Compounded GHK-Cu is not FDA-approved as a drug, and the quality and dosing of compounded peptides varies significantly across providers.

GHK-Cu does not cure any disease. It does not replace dermatological treatment. And the science, while interesting, is still early-stage for most of the claims that circulate on peptide-focused social media. Anyone telling you otherwise is getting ahead of the data.